PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Cradle Cap 21 Disease Disease Itching 5,798 1 0.00 -0.98 0.05 0.64
CAMK2D 21 Target Disease Seizures 66,465 2 0.00 -0.95 0.10 0.60
CAMK2D 21 Target Disease Inflammation 252,734 1 0.00 -0.98 0.05 0.55
Amevive (Alefacept)- FDA 21 Drug Disease Psoriasis 26,882 19 0.03 -0.31 0.90 0.68
Cradle Cap 21 Disease Disease Psoriasis 26,882 2 0.00 -0.95 0.10 0.62
Cradle Cap 21 Disease Disease Asthma 109,610 1 0.00 -0.98 0.05 0.57
Cradle Cap 21 Disease Disease Inflammation 252,734 2 0.00 -0.95 0.10 0.57
CAMK2D 21 Target Target CYR61 539 1 0.01 -0.97 0.05 0.71
Amevive (Alefacept)- FDA 21 Drug Disease Inflammation 252,734 1 0.00 -0.98 0.05 0.55
CAMK1D 21 Target Disease Breast Cancer 173,695 2 0.00 -0.95 0.10 0.57
CAMK2B 21 Target Disease Brain Tumors 16,749 1 0.00 -0.98 0.05 0.61
CAMK2B 21 Target Target EGF 27,487 1 0.00 -0.98 0.05 0.60
AMY2B 21 Target Disease Psoriasis 26,882 1 0.00 -0.98 0.05 0.60
AMY2B 21 Target Disease Scoliosis 14,102 1 0.00 -0.98 0.05 0.62
AMY2B 21 Target Target Alpha-Amylase 7,171 9 0.02 -0.76 0.43 0.70
AMY2B 21 Target Target APOA2 118 1 0.02 -0.97 0.05 0.76
AMY2B 21 Target Target Pancreatic Alpha-Amylase 423 3 0.03 -0.92 0.14 0.76
CAMK2B 21 Target Disease Glioblastoma 17,933 1 0.00 -0.98 0.05 0.61
CAMK2B 21 Target Target BDNF 11,163 1 0.00 -0.98 0.05 0.62
CAMK2B 21 Target Disease Breast Cancer 173,695 1 0.00 -0.98 0.05 0.56
CAMK2B 21 Target Disease Leukemia 162,805 1 0.00 -0.98 0.05 0.56
AMY2B 21 Target Target AMY1A 13 2 0.12 -0.87 0.15 0.87
Alefacept (Amevive)- FDA 21 Drug Drug Amevive (Alefacept)- FDA 21 21 1.00 -0.05 1.00 1.00
Alefacept (Amevive)- FDA 21 Drug Disease Psoriasis 26,882 19 0.03 -0.31 0.90 0.68
Alefacept (Amevive)- FDA 21 Drug Disease Inflammation 252,734 1 0.00 -0.98 0.05 0.55
Alefacept (Amevive)- FDA 21 Drug Drug Acitretin (Soriatane)- FDA 13 1 0.06 -0.94 0.08 0.84
CAMK1D 21 Target Disease Diabetic Nephropathy 12,496 1 0.00 -0.98 0.05 0.62
Ascorbic Acid (Vitamin C)- FDA 20 Drug Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Disease Infection 766,637 2 0.00 -0.95 0.10 0.55
BRSK1 20 Target Disease Breast Cancer 173,695 2 0.00 -0.95 0.10 0.58
4-1BB Receptor 20 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
4-1BB Receptor 20 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Target CD137 474 4 0.04 -0.89 0.20 0.76
4-1BB Receptor 20 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
4-1BB Receptor 20 Target Disease Shock 134,031 1 0.00 -0.97 0.05 0.57
4-1BB Receptor 20 Target Disease Influenza 67,933 1 0.00 -0.97 0.05 0.58
4-1BB Receptor 20 Target Disease Lung Carcinoma 13,423 1 0.00 -0.97 0.05 0.62
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
4-1BB Receptor 20 Target Disease Tuberculosis 146,217 1 0.00 -0.97 0.05 0.56
Ascorbic Acid (Vitamin C)- FDA 20 Drug Drug Adrenalin (Epinephrine)- FDA 42 2 0.07 -0.93 0.10 0.84
4-1BB Receptor 20 Target Disease Conjunctivitis 8,825 1 0.00 -0.97 0.05 0.63
Cyclooxygenase-3 20 Target Disease Pain 409,851 3 0.00 -0.92 0.15 0.57
Cyclooxygenase-3 20 Target Disease Dementia 66,782 1 0.00 -0.97 0.05 0.58
Cyclooxygenase-3 20 Target Target Platelet Activating Factor 9,915 1 0.00 -0.97 0.05 0.63
Cyclooxygenase-3 20 Target Target Cox-2 21,583 7 0.01 -0.81 0.35 0.66
BRSK1 20 Target Disease Menopause 19,680 8 0.01 -0.77 0.40 0.66
BRSK1 20 Target Disease Cholesterol 182,390 1 0.00 -0.97 0.05 0.56
Ascorbic Acid (Vitamin C)- FDA 20 Drug Target Sphingomyelinase 3,060 1 0.00 -0.97 0.05 0.66
Ascorbic Acid (Vitamin C)- FDA 20 Drug Drug Aquasol A (Vitamin A)- FDA 46 1 0.03 -0.96 0.05 0.80
Ascorbic Acid (Vitamin C)- FDA 20 Drug Disease Heart Disease 118,291 1 0.00 -0.97 0.05 0.57